Amarin Corp Plc (AMRN)

[Biobillionair]

Re:JPM Conference
1) Hikma presentation had a $750 million yearly opportunity on Vascepa; that’s obviously not just considering very high Trigs...attorney’s should view their slide deck...

2) GILD No significant mention of NASH but had one slide discussing bolt on acquisitions up to medium size and larger potential partner deals possible.

3) PFE is in 1 hour and 30 minutes, can’t wait to see slide deck there investors precautions state: my in bold emphasize

FORWARD-LOOKING STATEMENTS OF PFIZER INC.
This webcast may contain forward-looking statements about, among other things, our anticipated future operating and financial performance, business plans and prospects, in-line products and product candidates, strategic reviews, capital allocation, business-development plans, the benefits expected from the reorganization of our commercial operations into three businesses effective at the beginning of our 2019 fiscal year, our acquisitions and other business development activities, our proposed transaction with GSK to combine our respective consumer healthcare businesses into a new consumer healthcare joint venture, our ability to successfully capitalize on growth opportunities or prospects, manufacturing and product supply and plans relating to share repurchases and dividends, among other things, that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

A description of these risks and uncertainties can be found in Pfizer’s most recent Annual Report on Form 10-K and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Stay tuned....

BB